VFMFVanguard U.S. Multifactor ETF Shares
Seeks long-term capital appreciation by investing in U.S. common stocks with strong recent performance and fundamentals.
By Vanguard · Launched 2018
Annual Cost
0.18%
#794 of 6,040 · low cost
Fund Size
$976M
#1,196 of 6,040 · large
Return (1Y)
+30.4%
Track Record
8 years
#1,695 of 6,040 · established
Performance
Total-return NAV · USDGrowth of $10,000
$12,899+29.0%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 9.3% of funddiversified
Newmont Corp
1.1%
HCA Healthcare Inc
1.0%
Altria Group Inc
0.9%
McKesson Corp
0.9%
Bristol-Myers Squibb Co
0.9%
AbbVie Inc
0.9%
Merck & Co Inc
0.9%
Gilead Sciences Inc
0.9%
Micron Technology Inc
0.9%
Regeneron Pharmaceuticals Inc
0.9%
Asset allocation
Stocks
99.6%
Cash
0.4%
By sector
Financial Services
24.7%
Technology
14.9%
Healthcare
14.6%
Consumer Cyclical
11.9%
Energy
10.6%
Industrials
8.2%
Consumer Defensive
7.0%
Communication
4.6%
Other
3.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
12.6%Moderate
Year-on-year price swings
Max drawdown
-41.3%Severe
Worst peak-to-trough loss
Sharpe (3Y)
1.09Strong risk-adjusted returns
Sortino (3Y)
1.63Good downside protection
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long-term capital appreciation by investing in U.S. common stocks with strong recent performance and fundamentals.
- Strategy
- Employs an active management approach to invest primarily in U.S. common stocks with strong recent performance, strong fundamentals, and low prices relative to fundamentals. Targets large-, mid-, and small-cap companies to achieve exposure to multiple factors while promoting diversification.
- Inception date
- February 13, 2018
- Fund family
- Vanguard
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save VFMF to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18